Fenwick represented Oshi Health, a virtual gastrointestinal (GI) center of excellence, in its $60 million Series C funding. The round was led by Oak HC/FT with participation from existing investors Bessemer Venture Partners, Flare Capital Partners, Frist Cressey Ventures, CVS Health Ventures, and Takeda Digital Ventures.
Oshi Health will use the funds to add partnerships with more provider groups, grow payer coverage, service new employer partners, and expand into Medicare populations. More information can be obtained from the company’s announcement.
The Fenwick transaction team was led by corporate partner Evan Bienstock and included associates Stephanie Hong, Michelle Le, and Blair Mills.